These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 24011886)
1. Effects of antipsychotic medications on appetite, weight, and insulin resistance. Deng C Endocrinol Metab Clin North Am; 2013 Sep; 42(3):545-63. PubMed ID: 24011886 [TBL] [Abstract][Full Text] [Related]
2. Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives. Baptista T; Kin NM; Beaulieu S; de Baptista EA Pharmacopsychiatry; 2002 Nov; 35(6):205-19. PubMed ID: 12518268 [TBL] [Abstract][Full Text] [Related]
9. The implications of weight changes with antipsychotic treatment. Sussman N J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946 [TBL] [Abstract][Full Text] [Related]
10. [Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management]. Ruetsch O; Viala A; Bardou H; Martin P; Vacheron MN Encephale; 2005; 31(4 Pt 1):507-16. PubMed ID: 16389718 [TBL] [Abstract][Full Text] [Related]
11. Drug induced weight gain, an impediment to successful pharmacotherapy: focus on antipsychotics. Baptista T; Zárate J; Joober R; Colasante C; Beaulieu S; Páez X; Hernández L Curr Drug Targets; 2004 Apr; 5(3):279-99. PubMed ID: 15058313 [TBL] [Abstract][Full Text] [Related]
12. Distinct endocrine effects of chronic haloperidol or risperidone administration in male rats. Lin EJ; Lee NJ; Slack K; Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I; Herzog H; Sainsbury A Neuropharmacology; 2006 Dec; 51(7-8):1129-36. PubMed ID: 16919686 [TBL] [Abstract][Full Text] [Related]
13. [Atypical antipsychotic induced weight gain and metabolic disorders]. Rojas G P; Poblete A C; Orellana G X; Rouliez A K; Liberman G C Rev Med Chil; 2009 Jan; 137(1):106-14. PubMed ID: 19399331 [TBL] [Abstract][Full Text] [Related]
14. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness]. Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM; Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369 [TBL] [Abstract][Full Text] [Related]
15. Metformin for atypical antipsychotic-induced weight gain and glucose metabolism dysregulation: review of the literature and clinical suggestions. Hasnain M; Vieweg WV; Fredrickson SK CNS Drugs; 2010 Mar; 24(3):193-206. PubMed ID: 20155995 [TBL] [Abstract][Full Text] [Related]
16. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review. Koponen H; Saari K; Savolainen M; Isohanni M Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538 [TBL] [Abstract][Full Text] [Related]